Results 91 to 100 of about 2,783 (213)

Onchocerca volvulus microfilariae in the anterior chambers of the eye and ocular adverse events after a single dose of 8 mg moxidectin or 150 µg/kg ivermectin: results of a randomized double-blind Phase 3 trial in the Democratic Republic of the Congo, Ghana and Liberia

open access: yesParasites & Vectors
Background After ivermectin became available, diethylcarbamazine (DEC) use was discontinued because of severe adverse reactions, including ocular reactions, in individuals with high Onchocerca volvulus microfilaridermia (microfilariae/mg skin, SmfD ...
Eric M. Kanza   +19 more
doaj   +1 more source

Corneal blindness: a global perspective

open access: yesBulletin of the World Health Organization, 2001
Diseases affecting the cornea are a major cause of blindness worldwide, second only to cataract in overall importance. The epidemiology of corneal blindness is complicated and encompasses a wide variety of infectious and inflammatory eye diseases that ...
Whitcher John P.   +2 more
doaj  

Recognising ‘high-risk’ eyes before cataract surgery

open access: yesCommunity Eye Health Journal, 2008
Certain eyes are at a higher risk of complication during cataract surgery. Operations on such ‘high-risk’ eyes are also more likely to yield a poor visual outcome (defined as best corrected vision less than 6/60 after surgery).1Learning to recognise when
Parikshit Gogate, Mark Wood
doaj  

Onchocerciasis and non-communicable diseases in the Bafut Health District, Cameroon: Knowledge, attitudes, and practices towards community-directed treatment with ivermectin. [PDF]

open access: yesPLoS Negl Trop Dis
Ajonina-Ekoti IU   +10 more
europepmc   +1 more source

Modelling the effects of immigration on the re-introduction of onchocerciasis. [PDF]

open access: yesParasit Vectors
Stapley JN   +4 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy